Company performance
Add to research
Current Price
as of Jun 18, 2025$5.66
P/E Ratio
N/A
Market Cap
$267.32M
Description
Add to research
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
Metrics
Add to research
Overview
- HQLondon, GL
- SectorCommercial Services
- IndustryMiscellaneous Commercial Services
- TickerSLN
- Price$5.66+5.40%
Trading Information
- Market cap$267.32M
- Float79.63%
- Average Daily Volume (1m)122,050
- Average Daily Volume (3m)215,694
- EPS-$0.98
Company
- Revenue$43.28M
- Rev growth (1yr)-99.09%
- Net income-$28.64M
- Gross margin-9.51%
- EBITDA margin-18,022.54%
- EBITDA-$25.69M
- EV-$3.30M
- EV/Revenue-0.08
- P/EN/A
- P/S6.18
- P/B2.37
- Debt/Equity0.05
Documents
Add to research
SEC Filings
Factset Street Account